Combined endoscopic stent insertion in malignant biliary and duodenal obstruction. 2007

M Mutignani, and A Tringali, and S G Shah, and V Perri, and P Familiari, and F Iacopini, and C Spada, and G Costamagna
Digestive Endoscopy Unit, Catholic University, Rome, Italy.

OBJECTIVE Self-expandable metal stents (SEMS) are an effective palliative treatment for malignant biliary and duodenal strictures. Combined biliary and duodenal stenting remains a technical challenge, however. The aim of this study was to evaluate the technical feasibility of an endoscopic approach to double stenting of malignant biliary and duodenal strictures. METHODS Consecutive patients referred for palliative gastroduodenal and biliary stenting were followed up prospectively. Patients' demographic characteristics, the site and nature of the strictures, success rates, complications, and survival time were recorded. RESULTS A total of 64 patients underwent double stenting. In 46 patients, biliary obstruction occurred before the onset of duodenal obstruction (by a median of 107 days) (group 1); in 14 patients, biliary obstruction occurred concurrently with duodenal obstruction (group 2); and in four patients the duodenal obstruction preceded the biliary obstruction (by a median of 121 days) (group 3). The duodenal strictures were proximal to the papilla in 31 patients, adjacent to the papilla in 25 patients and distal to the papilla in eight patients. The majority of biliary strictures were in the middle or distal third of the bile duct (in 52/64 patients). Duodenal SEMS were successfully deployed in all patients. Combined endoscopic stenting was successful in 100% of patients in group 1, 86% of patients in group 2, and in 100% of patients in group 3. Taking the three groups together, early complications occurred in 6% of patients and late complications occurred in 16% of patients. The overall median survival after combined stenting was 81 days (range 2-447 days). CONCLUSIONS Combined endoscopic biliary and duodenal SEMS insertion is safe and effective for palliation in malignant biliary and duodenal obstruction. Biliary stenting through the mesh of the duodenal SEMS is technically feasible and has a high success rate.

UI MeSH Term Description Entries
D008297 Male Males
D010166 Palliative Care Care alleviating symptoms without curing the underlying disease. (Stedman, 25th ed) Palliative Treatment,Palliative Supportive Care,Palliative Surgery,Palliative Therapy,Surgery, Palliative,Therapy, Palliative,Care, Palliative,Palliative Treatments,Supportive Care, Palliative,Treatment, Palliative,Treatments, Palliative
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002779 Cholestasis Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS). Bile Duct Obstruction,Biliary Stasis,Bile Duct Obstructions,Biliary Stases,Cholestases,Duct Obstruction, Bile,Duct Obstructions, Bile,Obstruction, Bile Duct,Obstructions, Bile Duct,Stases, Biliary,Stasis, Biliary
D004380 Duodenal Obstruction Hindrance of the passage of luminal contents in the DUODENUM. Duodenal obstruction can be partial or complete, and caused by intrinsic or extrinsic factors. Simple obstruction is associated with diminished or stopped flow of luminal contents. Strangulating obstruction is associated with impaired blood flow to the duodenum in addition to obstructed flow of luminal contents. Duodenal Obstructions,Obstruction, Duodenal,Obstructions, Duodenal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015607 Stents Devices that provide support for tubular structures that are being anastomosed or for body cavities during skin grafting. Stent
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival

Related Publications

M Mutignani, and A Tringali, and S G Shah, and V Perri, and P Familiari, and F Iacopini, and C Spada, and G Costamagna
November 2017, Scandinavian journal of gastroenterology,
M Mutignani, and A Tringali, and S G Shah, and V Perri, and P Familiari, and F Iacopini, and C Spada, and G Costamagna
January 2003, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
M Mutignani, and A Tringali, and S G Shah, and V Perri, and P Familiari, and F Iacopini, and C Spada, and G Costamagna
August 2007, World journal of gastroenterology,
M Mutignani, and A Tringali, and S G Shah, and V Perri, and P Familiari, and F Iacopini, and C Spada, and G Costamagna
July 2010, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society,
M Mutignani, and A Tringali, and S G Shah, and V Perri, and P Familiari, and F Iacopini, and C Spada, and G Costamagna
October 2009, Gastrointestinal endoscopy,
M Mutignani, and A Tringali, and S G Shah, and V Perri, and P Familiari, and F Iacopini, and C Spada, and G Costamagna
December 2019, Endoscopy,
M Mutignani, and A Tringali, and S G Shah, and V Perri, and P Familiari, and F Iacopini, and C Spada, and G Costamagna
January 2019, Clinical endoscopy,
M Mutignani, and A Tringali, and S G Shah, and V Perri, and P Familiari, and F Iacopini, and C Spada, and G Costamagna
January 2006, Abdominal imaging,
M Mutignani, and A Tringali, and S G Shah, and V Perri, and P Familiari, and F Iacopini, and C Spada, and G Costamagna
January 2018, Scandinavian journal of gastroenterology,
M Mutignani, and A Tringali, and S G Shah, and V Perri, and P Familiari, and F Iacopini, and C Spada, and G Costamagna
July 2021, Journal of clinical medicine,
Copied contents to your clipboard!